NCT00461617View on ClinicalTrials.gov

Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

291

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Diabetes
Interventions
DRUG

Mitiglinide

10mg tablet, 10mg TID

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY